Cargando…

Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study

BACKGROUND: Despite major advances in cancer therapeutics, the therapeutic options of Lung Squamous Cell Carcinoma (LSCC)-specific remain limited. Furthermore, the current staging system is imperfect for defining a prognosis and guiding treatment due to its simplicity and heterogeneity. We sought to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Chen-ye, Luo, Jing, Ju, Sheng, Li, Chu-ling, Ding, Cheng, Chen, Jun, Liu, Xiao-long, Zhao, Jun, Yang, Li-qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542697/
https://www.ncbi.nlm.nih.gov/pubmed/37773106
http://dx.doi.org/10.1186/s12885-023-11309-z
_version_ 1785114147366633472
author Shao, Chen-ye
Luo, Jing
Ju, Sheng
Li, Chu-ling
Ding, Cheng
Chen, Jun
Liu, Xiao-long
Zhao, Jun
Yang, Li-qin
author_facet Shao, Chen-ye
Luo, Jing
Ju, Sheng
Li, Chu-ling
Ding, Cheng
Chen, Jun
Liu, Xiao-long
Zhao, Jun
Yang, Li-qin
author_sort Shao, Chen-ye
collection PubMed
description BACKGROUND: Despite major advances in cancer therapeutics, the therapeutic options of Lung Squamous Cell Carcinoma (LSCC)-specific remain limited. Furthermore, the current staging system is imperfect for defining a prognosis and guiding treatment due to its simplicity and heterogeneity. We sought to develop prognostic decision tools for individualized survival prediction and treatment optimization in elderly patients with LSCC. METHODS: Clinical data of 4564 patients (stageIB-IIIB) diagnosed from 2010 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database for prognostic nomograms development. The proposed models were externally validated using a separate group consisting of 1299 patients (stage IB-IIIB) diagnosed from 2012–2015 in China. The prognostic performance was measured using the concordance index (C-index), calibration curves, the average time-dependent area under the receiver operator characteristic curves (AUC), and decision curve analysis. RESULTS: Eleven candidate prognostic variables were identified by the univariable and multivariable Cox regression analysis. The calibration curves showed satisfactory agreement between the actual and nomogram-estimated Lung Cancer-Specific Survival (LCSS) rates. By calculating the c-indices and average AUC, our nomograms presented a higher prognostic accuracy than the current staging system. Clinical usefulness was revealed by the decision curve analysis. User-friendly online decision tools integrating proposed nomograms were created to estimate survival for patients with different treatment regimens. CONCLUSIONS: The decision tools for individualized survival prediction and treatment optimization might facilitate clinicians with decision-making, medical teaching, and experimental design. Online tools are expected to be integrated into clinical practice by using the freely available website (https://loyal-brand-611803.framer.app/). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11309-z.
format Online
Article
Text
id pubmed-10542697
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105426972023-10-03 Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study Shao, Chen-ye Luo, Jing Ju, Sheng Li, Chu-ling Ding, Cheng Chen, Jun Liu, Xiao-long Zhao, Jun Yang, Li-qin BMC Cancer Research BACKGROUND: Despite major advances in cancer therapeutics, the therapeutic options of Lung Squamous Cell Carcinoma (LSCC)-specific remain limited. Furthermore, the current staging system is imperfect for defining a prognosis and guiding treatment due to its simplicity and heterogeneity. We sought to develop prognostic decision tools for individualized survival prediction and treatment optimization in elderly patients with LSCC. METHODS: Clinical data of 4564 patients (stageIB-IIIB) diagnosed from 2010 to 2015 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database for prognostic nomograms development. The proposed models were externally validated using a separate group consisting of 1299 patients (stage IB-IIIB) diagnosed from 2012–2015 in China. The prognostic performance was measured using the concordance index (C-index), calibration curves, the average time-dependent area under the receiver operator characteristic curves (AUC), and decision curve analysis. RESULTS: Eleven candidate prognostic variables were identified by the univariable and multivariable Cox regression analysis. The calibration curves showed satisfactory agreement between the actual and nomogram-estimated Lung Cancer-Specific Survival (LCSS) rates. By calculating the c-indices and average AUC, our nomograms presented a higher prognostic accuracy than the current staging system. Clinical usefulness was revealed by the decision curve analysis. User-friendly online decision tools integrating proposed nomograms were created to estimate survival for patients with different treatment regimens. CONCLUSIONS: The decision tools for individualized survival prediction and treatment optimization might facilitate clinicians with decision-making, medical teaching, and experimental design. Online tools are expected to be integrated into clinical practice by using the freely available website (https://loyal-brand-611803.framer.app/). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-11309-z. BioMed Central 2023-09-29 /pmc/articles/PMC10542697/ /pubmed/37773106 http://dx.doi.org/10.1186/s12885-023-11309-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shao, Chen-ye
Luo, Jing
Ju, Sheng
Li, Chu-ling
Ding, Cheng
Chen, Jun
Liu, Xiao-long
Zhao, Jun
Yang, Li-qin
Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
title Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
title_full Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
title_fullStr Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
title_full_unstemmed Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
title_short Online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
title_sort online decision tools for personalized survival prediction and treatment optimization in elderly patients with lung squamous cell carcinoma: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542697/
https://www.ncbi.nlm.nih.gov/pubmed/37773106
http://dx.doi.org/10.1186/s12885-023-11309-z
work_keys_str_mv AT shaochenye onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT luojing onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT jusheng onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT lichuling onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT dingcheng onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT chenjun onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT liuxiaolong onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT zhaojun onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy
AT yangliqin onlinedecisiontoolsforpersonalizedsurvivalpredictionandtreatmentoptimizationinelderlypatientswithlungsquamouscellcarcinomaaretrospectivecohortstudy